A nearly 13-year-old skin cancer drug rapidly alleviates molecular signs of Alzheimer's diseas e and improves brain function, according to the results of a new mouse study being hailed as extremely promising.
Read More »A nearly 13-year-old skin cancer drug rapidly alleviates molecular signs of Alzheimer's diseas e and improves brain function, according to the results of a new mouse study being hailed as extremely promising.
Read More »